Acuity Functional Impact and Implementation Outcomes Evaluation
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- Experiad LLC
- 入组人数
- 102
- 试验地点
- 2
- 主要终点
- Increased frequency of changes to programs and prescribed dosages, resulting in reduced Trials to Criterion and Time to Criterion.
研究概览
简要总结
This study will test feature enhancements to a behavioral therapy data collection software (Motivity) that will add a new clinical decision support module, called Acuity. Acuity is a Quality Improvement (QI) intervention targeted at Behavior Analysts (BAs) and Behavior Technicians (BTs) that aims to improve the delivery of autism behavioral therapy. Subjects will be staff recruited from existing Motivity customers.
详细描述
Acuity is intended to provide significant improvements in treatment planning, progress tracking, trend monitoring, and dosage management. If successful, Acuity will provide Applied Behavior Analysis (ABA) practitioners with a higher level of real-time insight into their clinical data, enabling more efficient and productive treatment. Research has shown that first-generation systems fall short in supporting overworked BAs who are overwhelmed with data. Acuity will address critical shortfalls by enabling more agile corrective actions and data-driven planning across multiple aspects of treatment, providing practitioners with new levels of rigorous, real-time insight into their clinical data. Acuity will help BAs establish and adhere to realistic treatment timelines, and will proactively alert the BA to noteworthy trends in the data as they occur, such as learner performance issues, missed dosages, and significant changes in tracked behaviors. In doing so, Acuity will support more responsive and effective treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Behavior Analysts and Behavior Technicians treating kids with autism
- •Must be employed by one of the autism treatment clinics that have agreed to participate in the study.
- •Must be employed by Experiad customers who are using Motivity software as part of their practice.
排除标准
- •All people not listed above
结局指标
主要结局
Increased frequency of changes to programs and prescribed dosages, resulting in reduced Trials to Criterion and Time to Criterion.
时间窗: through study completion, expected to be 18 months from the start of retroactive observation period
Does Acuity result in corrective action being taken more quickly for programs that are off schedule or targets that are exhibiting performance issues?
Number of participants with improved estimation of Trials to Criterion and Time (days) to Criterion
时间窗: through study completion, expected to be 18 months from the start of retroactive observation period
Does Acuity make initial timeline estimates for sets of targets more accurate?
Proportion of clinics and providers that actively use Acuity, assessed by system usage tracking.
时间窗: at the end of the study, expected to be 18 months from the start of retroactive observation period
Adoption - What proportion of clinics and providers are willing to use Acuity and how well do they represent the population of clinics and providers?
Number of participants who find Acuity and its components practical and possible to use, assessed by qualitative measures and system usage tracking
时间窗: at the end of the study, expected to be 18 months from the start of retroactive observation period
Feasibility - To what extent are Acuity and its components practical or possible to use?
Number of BAs & BTs who utilize Acuity as intended to provide learners with accurate treatment plans, and achieve expected results, as measured by system usage and qualitative assessment.
时间窗: at the end of the study, expected to be 18 months from the start of retroactive observation period
Fidelity - the degree to which BAs and BTs use the system as expected, including dosage adherence, treatment planning accuracy, and timely protocol modification.
Majority of BAs and BTs rate Acuity and its components as attractive, agreeable, or palatable.
时间窗: at the end of the study, expected to be 18 months from the start of retroactive observation period
Acceptability, as measured by SUS score and SUS Items 1, 5, 6 \& 8 collected via online survey at the end of O0 \& O1 from both arms.
Increased adherence to prescribed dosage
时间窗: through study completion, expected to be 18 months from the start of retroactive observation period
Does Acuity result in increased adherence to prescribed dosage, as measured by system
Frequency at which Acuity and its components are rated as suitable, fitting, or proper for achieving the goals set forth in treatment plans, as measured by surveys.
时间窗: at the end of the study, expected to be 18 months from the start of retroactive observation period
Appropriateness - Same measures captured for all primary \& secondary research questions in the Functional Impact Evaluation. Brief online survey with Likert scaled items focused on the providers' assessment of how well Acuity and its components are matched to the challenges of planning and executing Treatment Plans.
次要结局
未报告次要终点